Intravenous (IV) Solution Market Insights, Forecast to 2025

Intravenous (IV) Solution

This report studies the global market size of Intravenous (IV) Solution Market in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intravenous (IV) Solution in these regions.

This research report categorizes the global Intravenous (IV) Solution market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

Download FREE Sample of this Report @

Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls.

Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly.

In 2017, the global Intravenous (IV) Solution market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Intravenous (IV) Solution market based on company, product type, application and key regions.

The various contributors involved in the value chain of Intravenous (IV) Solution include manufacturers, suppliers, distributors, intermediaries, and customers.

The key manufacturers in the Intravenous (IV) Solution include

  • ICU Medical
  • B. Braun Melsungen
  • Fresenius Kabi
  • Baxter
  • Amanta Healthcare
  • Terumo Medical Corporation
  • Grifols

Market Size Split by Type

  • by Product Type
  • Total Parenteral Solution
  • Peripheral Parenteral Solution
  • by Nutritional Content
  • Amino Acid Solution
  • Carbohydrates
  • Vitamins & Minerals
  • Parenteral Lipid Emulsion
  • Others

Market Size Split by Application

  • Hospitals & Clinics
  • Ambulatory
  • Homecare

Market size split by Region

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Singapore
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Central & South America
  • Brazil
  • Rest of Central & South America
  • Middle East & Africa
  • GCC Countries
  • Turkey
  • Egypt
  • South Africa

The study objectives of this report are:

  • To study and analyze the global Intravenous (IV) Solution market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
  • To understand the structure of Intravenous (IV) Solution market by identifying its various subsegments.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • Focuses on the key global Intravenous (IV) Solution manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Intravenous (IV) Solution with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To project the value and volume of Intravenous (IV) Solution submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Intravenous (IV) Solution are as follows:

  • History Year: 2013–2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intravenous (IV) Solution market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get the Complete Report & TOC @

Table of content

1 Study Coverage
1.1 Intravenous (IV) Solution Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Intravenous (IV) Solution Market Size Growth Rate by Type
1.4.2 Total Parenteral Solution
1.4.3 Peripheral Parenteral Solution
1.5 Market by Application
1.5.1 Global Intravenous (IV) Solution Market Size Growth Rate by Application
1.5.2 Hospitals & Clinics
1.5.3 Ambulatory
1.5.4 Homecare
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Intravenous (IV) Solution Market Size
2.1.1 Global Intravenous (IV) Solution Revenue 2016–2025
2.1.2 Global Intravenous (IV) Solution Sales 2016–2025
2.2 Intravenous (IV) Solution Growth Rate by Regions
2.2.1 Global Intravenous (IV) Solution Sales by Regions
2.2.2 Global Intravenous (IV) Solution Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Intravenous (IV) Solution Sales by Manufacturers
3.1.1 Intravenous (IV) Solution Sales by Manufacturers
3.1.2 Intravenous (IV) Solution Sales Market Share by Manufacturers
3.1.3 Global Intravenous (IV) Solution Market Concentration Ratio (CR5 and HHI)
3.2 Intravenous (IV) Solution Revenue by Manufacturers
3.2.1 Intravenous (IV) Solution Revenue by Manufacturers (2016–2018)

If You Have Any Question Related To This Report Contact Us @

276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170

Follow Us On linkedin :-